Sodium‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sodium‐glucose cotransporter 2 inhibitor effects on heart failure hospitalization and cardiac function: systematic review

Published:2021-07-05 Issue:5 Volume:8 Page:4093-4118
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Rasalam Roy¹^ORCID,Atherton John J.²,Deed Gary³,Molloy‐Bland Michael⁴,Cohen Neale⁵,Sindone Andrew⁶

Affiliation:

1. College of Medicine & Dentistry James Cook University Townsville QLD Australia

2. Royal Brisbane and Women's Hospital, Faculty of Medicine University of Queensland Herston QLD Australia

3. Mediwell Medical Clinic Coorparoo QLD Australia

4. Oxford PharmaGenesis Melbourne VIC Australia

5. Baker Heart and Diabetes Institute Melbourne VIC Australia

6. Concord Hospital University of Sydney Concord NSW Australia

Funder

AstraZeneca

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13483

Reference92 articles.

1. SGLT2 inhibition — a novel strategy for diabetes treatment

2. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

3. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

4. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

5. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes;Journal of Diabetes Investigation;2024-09-10

2. Empagliflozin attenuates trastuzumab-induced cardiotoxicity through suppression of DNA damage and ferroptosis;Life Sciences;2023-01

3. The Association Between On-treatment Ambulatory Central Blood Pressure and Left Ventricular Reverse Remodeling in Heart Failure With Reduced Ejection Fraction;International Journal of Heart Failure;2023

4. Sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fraction: A meta-analysis of randomized controlled trials;IJC Heart & Vasculature;2022-10

5. Potential Benefits of Sodium-Glucose Transporter-2 Inhibitors in the Symptomatic and Functional Status of Patients With Heart Failure: A Systematic Review and Meta-Analysis;Cureus;2022-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3